+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study



Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study



Circulation 119(10): 1363-1369



Atrial fibrillation (AF) substantially increases the risk of ischemic stroke, but this risk varies among individual patients with AF. Existing risk stratification schemes have limited predictive ability. Chronic kidney disease is a major cardiovascular risk factor, but whether it independently increases the risk for ischemic stroke in persons with AF is unknown. We examined how chronic kidney disease (reduced glomerular filtration rate or proteinuria) affects the risk of thromboembolism off anticoagulation in patients with AF. We estimated glomerular filtration rate using the Modification of Diet in Renal Disease equation and proteinuria from urine dipstick results found in laboratory databases. Patient characteristics, warfarin use, and thromboembolic events were ascertained from clinical databases, with validation of thromboembolism by chart review. During 33,165 person-years off anticoagulation among 10,908 patients with AF, we observed 676 incident thromboembolic events. After adjustment for known risk factors for stroke and other confounders, proteinuria increased the risk of thromboembolism by 54% (relative risk, 1.54; 95% CI, 1.29 to 1.85), and there was a graded, increased risk of stroke associated with a progressively lower level of estimated glomerular filtration rate compared with a rate > or =60 mL x min(-1) x 1.73 m(-2): relative risk of 1.16 (95% CI, 0.95 to 1.40) for estimated glomerular filtration rate of 45 to 59 mL x min(-1) x 1.73 m(-2) and 1.39 (95% CI, 1.13 to 1.71) for estimated glomerular filtration rate <45 mL x min(-1) x 1.73 m(-2) (P=0.0082 for trend). Chronic kidney disease increases the risk of thromboembolism in AF independently of other risk factors. Knowing the level of kidney function and the presence of proteinuria may improve risk stratification for decision making about the use of antithrombotic therapy for stroke prevention in AF.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053722799

Download citation: RISBibTeXText

PMID: 19255343

DOI: 10.1161/circulationaha.108.816082


Related references

Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation 102(1): 11-13, 2000

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 112(12): 1687-1691, 2005

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Journal of Thrombosis and Thrombolysis 15(1): 41-46, 2003

Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Journal of the American Heart Association 5(7):, 2016

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Annals of Internal Medicine 131(12): 927-934, 1999

Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA (Journal of the American Medical Association) 285(18): 2370-2375, 2001

The impact of anticoagulation intensity on severity of stroke in atrial fibrillation The anticoagulation and risk factors in atrial fibrillation study. Circulation. 106(19 Suppl.): Ii-577-Ii-578, Ember 5, 2002

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 127(2): 224-232, 2013

The impact of age on intracranial hemorrhage and 30-day mortality in patients with atrial fibrillation The anticoagulation and risk factors in atrial fibrillation Study. Circulation. 108(17 Suppl.): Iv-766-Iv-767, Ober 28, 2003

Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The An Ticoagulation and Risk factors In Atrial fibrillation (ATRIA) Study. Yearbook of Cardiology 2006: 415-416, 2006

Thromboembolism vs anticoagulation intensity in high-risk patients with atrial fibrillation The stroke prevention in atrial fibrillation III study. Circulation 94(8 Suppl. ): I33-I34, 1996

Anticoagulation intensity and risk of stroke and intracranial hemorrhage in atrial fibrillation The anticoaguation and risk factors in atrial fibrillation Study. Circulation 104(17 Suppl.): II 794, 2001

What is the optimal anticoagulation intensity to prevent stroke in patients with atrial fibrillation =75 versus 75 years old? The anticoagulation and risk factors in atrial fibrillation study. Journal of the American College of Cardiology 39(5 Suppl. A): 133A, 2002

Factor V Leiden mutation and risk of stroke in atrial fibrillation The anticoagulation and risk factors in atrial fibrillation study. Circulation 104(17 Suppl.): II 530, 2001

The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study. Chest 146(5): 1337-1346, 2015